Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sabrina Champsi
Observed names:
Champsi, Sabrina,
S. Champsi,
SABRINA CHAMPSI
Institution:
York University
Observed institution:
York University
ORCID:
0009-0000-1971-3025
Observed ORCID:
0009-0000-1971-3025
OpenAlex ID:
A5046870866
Regulation of lysosomes in skeletal muscle during exercise, disuse and aging
2024
·
N. Moradi
, V.C. Sanfrancesco
, et al.
·
Free Radical Biology and Medicine
·
31
Sulforaphane, Urolithin A, and ZLN005 induce time-dependent alterations in antioxidant capacity, mitophagy, and mitochondrial biogenesis in muscle cells
2024
·
Neushaw Moradi
, Sabrina Champsi
, et al.
·
Sports Medicine and Health Science
·
11
Sulforaphane treatment mimics contractile activity-induced mitochondrial adaptations in muscle myotubes
2024
·
Sabrina Champsi
, David A. Hood
·
American Journal of Physiology-Cell Physiology
·
10
Role of Prohibitins as Guardians of mitochondrial homeostasis
2025
·
Sabrina Champsi
, David A. Hood
·
Mitochondrion
·
5
Mitochondrial Biogenesis in Skeletal Muscle
2025
·
David A. Hood
, Jonathan M. Memme
, et al.
·
Advances in experimental medicine and biology
·
4
Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes
2024
·
Ninoschka C. D’Souza
, Julian A. Aiken
, et al.
·
Frontiers in Pharmacology
·
4
PDF
The epigenetic landscape of skeletal muscle in response to exercise and aging
2026
·
Sabrina Champsi
, David A. Hood
·
FEBS Journal
·
1
1-LB: Evaluating the Effectiveness of the Novel Somatostatin Receptor Antagonist (SSTR2a) ZT-01 for Hypoglycemia Prevention in a Rodent Model of Type 2 Diabetes
2023
·
NINOSCHKA C. D'SOUZA
, JULIAN AIKEN
, et al.
·
Diabetes
·
1
2-LB: Effect of Somatostatin Receptor 2 Antagonism (SSTR2a) on Oral Glucose Tolerance (OGT) in a Rat Model of Type 2 Diabetes (T2D)
2023
·
NINOSCHKA C. D'SOUZA
, NADIA ALEALI
, et al.
·
Diabetes
·
1
One Week Exposure to a Somatostatin Receptor 2 Antagonist ( SSTR2a ) Enhances Glucagon Counterregulation to Insulin‐Induced Hypoglycaemia and Does Not Worsen Glycemia in a Male Rat Model of Insulin‐Requiring Type 2 Diabetes
2026
·
Ninoschka C. D'Souza
, Emily G. Hoffman
, et al.
·
Diabetes Obesity and Metabolism
Author response for "One week exposure to a somatostatin receptor 2 antagonist (SSTR2a) enhances glucagon counterregulation to insulin-induced hypoglycaemia and does not worsen glycemia in a male rat model of insulin-requiring type 2 diabetes"
2026
·
Ninoschka C. D'Souza
, Emily G. Hoffman
, et al.
Abstract 056 | Role of prohibitin isoforms in mitochondrial function with aging and exercise
2026
·
Sabrina Champsi
·
European Journal of Translational Myology
PDF
Prohibitins are required for the induction of mitochondrial quality control mechanisms and the integrated stress response in skeletal muscle cells
2025
·
Sabrina Champsi
, David A. Hood
·
Physiology
Focus on the Forgotten Organelle: Regulation of Lysosomes in Skeletal Muscle
2025
·
Neushaw Moradi
, Anastasiya Kuznyetsova
, et al.
·
Exercise and Sport Sciences Reviews
Mitochondrial Biogenesis
2025
·
Sabrina Champsi
, David A. Hood
·
Springer eBooks
Activation of the Nrf-2 pathway improves the mitochondrial phenotype in skeletal muscle cells
2024
·
Sabrina Champsi
, David A. Hood
·
Physiology
1197-P: Effect of Somatostatin Receptor 2 Antagonist (SSTR2a) on Glycemia and Glucagon Levels in a Rat Model of Type 2 Diabetes (T2D)
2021
·
NINOSCHKA C. D'SOUZA
, EMILY G. HOFFMAN
, et al.
·
Diabetes
Show more works
View as search
Works count:
20
Citation count:
68
H-index:
4
I10-index:
3
Year
Topic
Type
